Article
The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
Oncogene - 6 Aug 2009
Roovers K, Wagner S, Storbeck C J, O'Reilly P, Lo V, Northey J J, Chmielecki J, Muller W J, Siegel P M, Sabourin L A
Abstract excerpt
The Ste20-like kinase, SLK, is involved in the control of cell motility through its effects on actin reorganization and focal adhesion turnover. Here we investigated the role of SLK in chemotaxis downstream of the tyrosine kinase receptor, HER2/ErbB2/Neu, which is frequently overexpressed in human breast cancers. Our results show that SLK is required for the efficient cell migration of human and mouse mammary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
